The stock of Blue Water Vaccines Inc. (NASDAQ:BWV) last traded at $1.37, up 9.60% from the previous session.
Data from the available sources indicates that Blue Water Vaccines Inc. (NASDAQ:BWV) is covered by 2 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $7.00 and a low of $4.00, we find $5.50. Given the previous closing price of $1.25, this indicates a potential upside of 340.0 percent. BWV stock price is now 16.22% away from the 50-day moving average and -60.77% away from the 200-day moving average. The market capitalization of the company currently stands at $19.30M.
In total, 0 analysts have assigned it a hold rating, and 2 have given it a buy rating. Brokers who have rated the stock have averaged $5.50 as their price target over the next twelve months.
In other news, Hernandez Joseph, CEO sold 30,269 shares of the company’s stock on Aug 22. The stock was sold for $124,206 at an average price of $4.10. Upon completion of the transaction, the CEO now directly owns 2,650,351 shares in the company, valued at $3.63 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 19, Director Shaw Allan sold 29,636 shares of the business’s stock. A total of $116,766 was realized by selling the stock at an average price of $3.94. Insiders disposed of 1,834,119 shares of company stock worth roughly $2.51 million over the past 1 year. A total of 17.30% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in BWV stock. A new stake in Blue Water Vaccines Inc. shares was purchased by ARMISTICE CAPITAL, LLC during the first quarter worth $1,176,000. CETERA ADVISOR NETWORKS LLC invested $182,000 in shares of BWV during the first quarter. In the first quarter, VANGUARD GROUP INC acquired a new stake in Blue Water Vaccines Inc. valued at approximately $62,000. MILLENNIUM MANAGEMENT LLC acquired a new stake in BWV for approximately $54,000. TWO SIGMA INVESTMENTS, LP purchased a new stake in BWV valued at around $47,000 in the second quarter. In total, there are 13 active investors with 20.50% ownership of the company’s stock.
With an opening price of $1.2500 on Friday morning, Blue Water Vaccines Inc. (NASDAQ: BWV) set off the trading day. During the past 12 months, Blue Water Vaccines Inc. has had a low of $0.91 and a high of $90.90. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 6.80, and a quick ratio of 6.80. The fifty day moving average price for BWV is $1.1836 and a two-hundred day moving average price translates $3.1843 for the stock.
The latest earnings results from Blue Water Vaccines Inc. (NASDAQ: BWV) was released for Jun, 2022.
Blue Water Vaccines Inc.(BWV) Company Profile
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company’s lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also develops other products that are under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.